Skip to search formSkip to main contentSkip to account menu

Trilafon

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Psychiatrists regularly fail to obtain informed consent by not fully informing their patients of the risks of psychotropic drugs… 
2004
2004
Thirteen acute psychotic patients received continuous oral treatment with perphenazine for a period of 8 weeks. Blood samples for… 
Highly Cited
1973
Highly Cited
1973
ABSTRACT In order to evaluate the effects of estrogen on stimulated prolactin secretion in man, 8 mg perphenazine (Trilafon®) was… 
1968
1968
Mammary growth and secretion were produced in adult female Sprague-Dawley rats by daily administration of 5 mg/k/day of… 
1965
1965
SummaryA comparative trial of thiethylperazine (Torecan®), perphenazine (Trilafon®) and trimethobenzamide (Tigan®) has been… 
1960
1960
The present study demonstrated that perphenazine is a potent antiemetic drug with very few side effects. A single injection of 5… 
1959
1959
There is a perpetual endeavor on the part of the clinician and the pharmaceutical houses to find a drug or combination of drugs… 
1958
1958
The purpose of this study was to evaluate the effect of a new tranquilizing agent, perphenazine (Trilafon) in dermatologic…